Merrimack Pharmaceuticals, Inc. (MACK)

[$Pistol Pete$]

$MACK ~ Merrimack Pharmaceuticals, Inc. due diligence report

$MACK recent news/filings

## source: finance.yahoo.com

Fri, 23 Oct 2015 21:23:19 GMT ~ Pandora and Alphabet are big market movers


read full: http://sg.finance.yahoo.com/news/pandora-alphabet-big-market-movers-203652038.html
*********************************************************

Fri, 23 Oct 2015 04:15:00 GMT ~ PharmaEngine Announces U.S. FDA Approves Merrimack's ONIVYDE(TM) (irinotecan liposome injection)

[PR Newswire] - TAIPEI, Taiwan, Oct. 23, 2015 /PRNewswire/ -- PharmaEngine, Inc. (TWO: 4162) announced the U.S. FDA has approved Merrimack's (NASDAQ: MACK) ONIVYDE TM (irinotecan liposome injection) in combination with ...

read full: http://finance.yahoo.com/news/pharmaengine-announces-u-fda-approves-041500847.html
*********************************************************

Thu, 22 Oct 2015 17:39:14 GMT ~ Merrimack Announces U.S. FDA Approval of ONIVYDE™ (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer

[at noodls] - CAMBRIDGE, Mass., Oct. 22, 2015 /PRNewswire/ -- Merrimack (Nasdaq: MACK) today announced that ONIVYDE™ (irinotecan liposome injection) has been approved by the U.S. Food and Drug Administration (FDA) in ...

read full: http://www.noodls.com/view/25E2F4522F1FCB788EFB19E16DED2DF22AC5C8C5
*********************************************************

Thu, 22 Oct 2015 17:26:40 GMT ~ FDA clears Merrimack's pancreatic cancer drug with warning

[Reuters] - The U.S. Food and Drug Administration approved Merrimack Pharmaceutical Inc's pancreatic cancer therapy Onivyde, but with a serious warning, marking the company's first ever drug to win regulatory clearance. The drug in combination with chemotherapy treatments 5-fluorouracil and leucovorin treats metastatic pancreatic cancer in patients, who have failed to respond to chemotherapy drug gemcitabine. Onivyde, however, carries a black box warning about severe risks of diarrhea and low white blood cell count, the agency said, adding that it was not approved for use as a single agent.

read full: http://finance.yahoo.com/news/merrimack-pharmas-cancer-drug-wins-162116614.html
*********************************************************

Thu, 22 Oct 2015 17:11:00 GMT ~ Merrimack Announces U.S. FDA Approval of ONIVYDE™ (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer

[PR Newswire] - CAMBRIDGE, Mass., Oct. 22 , 2015 /PRNewswire/ -- Merrimack (Nasdaq: MACK) today announced that ONIVYDE™ (irinotecan liposome injection) has been approved by the U.S. Food and Drug Administration (FDA) ...

read full: http://finance.yahoo.com/news/merrimack-announces-u-fda-approval-171100110.html
*********************************************************

$MACK charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$MACK company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/MACK/company-info
Ticker: $MACK
OTC Market Place: Not Available
CIK code: not found
Company name: Merrimack Pharmaceuticals, Inc.
Incorporated In:

Business Description:


$MACK share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$MACK extra dd links

Company name: Merrimack Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/MACK/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/MACK/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=MACK+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=MACK+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=MACK+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/MACK/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/MACK/news - http://finance.yahoo.com/q/h?s=MACK+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/MACK/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/MACK/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/MACK/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/MACK/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/MACK/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/MACK/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/MACK/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/MACK/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=MACK+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/MACK
DTCC (dtcc.com): http://search2.dtcc.com/?q=Merrimack+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Merrimack+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Merrimack+Pharmaceuticals%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/MACK/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/MACK
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/MACK/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/MACK/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/MACK/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/MACK/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/MACK/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/MACK/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/MACK/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=MACK&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=MACK
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/MACK/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=MACK+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=MACK+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=MACK
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=MACK
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=MACK+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/MACK/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=MACK+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/MACK.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=MACK
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/MACK/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/MACK/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/MACK/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/MACK/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/MACK
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/MACK
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/MACK:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=MACK
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=MACK